Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity.
CAP23 is a major cortical cytoskeleton-associated and calmodulin binding protein that is widely and abundantly expressed during development, maintained in selected brain structures in the adult, and reinduced during nerve regeneration. Overexpression of CAP23 in adult neurons of transgenic mice promotes nerve sprouting, but the role of this protein in process outgrowth was not clear. Here, we show that CAP23 is functionally related to GAP43, and plays a critical role to regulate nerve sprouting and the actin cytoskeleton. Knockout mice lacking CAP23 exhibited a pronounced and complex phenotype, including a defect to produce stimulus-induced nerve sprouting at the adult neuromuscular junction. This sprouting deficit was rescued by transgenic overexpression of either CAP23 or GAP43 in adult motoneurons. Knockin mice expressing GAP43 instead of CAP23 were essentially normal, indicating that, although these proteins do not share homologous sequences, GAP43 can functionally substitute for CAP23 in vivo. Cultured sensory neurons lacking CAP23 exhibited striking alterations in neurite outgrowth that were phenocopied by low doses of cytochalasin D. A detailed analysis of such cultures revealed common and unique functions of CAP23 and GAP43 on the actin cytoskeleton and neurite outgrowth. The results provide compelling experimental evidence for the notion that CAP23 and GAP43 are functionally related intrinsic determinants of anatomical plasticity, and suggest that these proteins function by locally promoting subplasmalemmal actin cytoskeleton accumulation.
Frey
D
D
Friedrich Miescher Institute, CH-4058 Basel, Switzerland.
Laux
T
T
Xu
L
L
Schneider
C
C
Caroni
P
P
D000199:Actins / Q000378:metabolism*; D000367:Age Factors; D000818:Animals; D019274:Botulinum Toxins, Type A / Q000494:pharmacology; D001921:Brain / Q000166:cytology / Q000378:metabolism* / Q000502:physiology*; D002148:Calmodulin-Binding Proteins; D002478:Cells, Cultured; D015638:Cytochalasin D / Q000494:pharmacology; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D003599:Cytoskeleton / Q000378:metabolism; D019922:GAP-43 Protein / Q000378:metabolism*; D005727:Ganglia, Spinal / Q000166:cytology / Q000378:metabolism; D020439:Growth Cones / Q000378:metabolism / Q000648:ultrastructure; D051379:Mice; D018345:Mice, Knockout; D009046:Motor Neurons / Q000166:cytology / Q000378:metabolism; D009412:Nerve Fibers / Q000378:metabolism / Q000648:ultrastructure; D009419:Nerve Tissue Proteins; D016501:Neurites / Q000378:metabolism* / Q000502:physiology*; D009465:Neuromuscular Agents / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000378:metabolism / Q000648:ultrastructure; D009473:Neuronal Plasticity / Q000502:physiology*; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology; D010641:Phenotype; D011108:Polymers / Q000378:metabolism
D000199:Actins; C489363:Basp1 protein, mouse; D002148:Calmodulin-Binding Proteins; D003598:Cytoskeletal Proteins; D019922:GAP-43 Protein; D009419:Nerve Tissue Proteins; D009465:Neuromuscular Agents; D019384:Nucleic Acid Synthesis Inhibitors; D011108:Polymers; D015638:Cytochalasin D; D019274:Botulinum Toxins, Type A